Sorry to hear you lost money on this. At the time I mentioned Ocugen on this board, just a few months ago, it was selling at $0.56 per share. As I write this, it is at $1.76 per share.
I’m definitely staying in. I bought my first 300 shares 3 years ago at $10 per share, and kept buying more as the price kept dropping, all the way down to $0.35 per share, because I believe in the company and the products they’re developing.
Today I have 15,000 shares at 1.69 average. I won’t sell any until it hits almost $5 per share, which I believe will happen this year. Even then I will keep 80% of my holdings longer term.
The catalysts going forward, now that they’ve achieved NASDAQ compliance, include a forthcoming partnership with a big pharma company (rumored to be JnJ but that’s just random speculation because both companies are developing ocular degeneration treatments).
They are starting phase 3 trials next month for one of their ocular treatments and they have started building a factory to manufacture their knee cartilage product.
They also have a nasal delivery vaccine in development.
Please note that I am only sharing what I know and why I’ve been accumulating shares of this stock. None of what I’m saying is intended to be advice or even a recommendation.
Hope this helps, good luck.